Alembic Pharma Latest News

  1. There were no 483s issued by USFDA at the end of the inspection
    Date:21-08-2019
  2. There were no 483s issued by USFDA at the end of the inspection
    Date:21-08-2019
  3. The approved ANDA is therapeutically equivalent to the reference listed drug product Tricor Tablets, 48 mg and 145 mg, of AbbVie
    Date:13-08-2019
  4. Alembic Pharmaceuticals has informed that the Company has received US Food & Drug Administration (USFDA) Approval for Dorzolamide Hydrochloride Ophthalmic Solution USP, 2%. The company has also submitted its press relea...

    Date:13-08-2019
  5. The approved ANDA is therapeutically equivalent to the RLD Trusopt Ophthalmic Solution
    Date:13-08-2019
  6. Alembic now has a total of 100 ANDA approvals from USFDA
    Date:09-08-2019
  7. Alembic now has a total of 100 ANDA approvals from USFDA
    Date:09-08-2019
  8. Alembic now has a total of 99 ANDA approvals (88 final approvals and 11 tentative approvals) from USFDA
    Date:23-07-2019
  9. Alembic now has a total of 99 ANDA approvals (88 final approvals and 11 tentative approvals) from USFDA
    Date:23-07-2019
  10. Alembic Pharmaceuticals has informed that the Company has received US Food & Drug Administration (USFDA) Approval for Pregabalin Capsules, 25 mg, 50 mg, 75 mg, 100 mg, 150 mg, 200 mg, 225 mg, and 300 mg. 

    Date:22-07-2019
Return to Top
Puchho Befikar